Vindinglevin8522

The molecular weight of 0.200 kb demonstrated the strongest anti-HPY effect, with the antibacterial effect observed for up to 134 h. Metal ions such as NaCl and MgCl₂ affected the anti-HPY effect of chitosan; with increasing concentration, the antibacterial percentage decreased.In this study, we aim to investigate the effects of nano-cerium oxide (CNPs) on the proliferation of hepatoma cells and expression of the Bcl-2 and Bax mRNAs. Huh7, 7721 and HepG2 liver cancer cells were cultured in vitro and treated with CNPs at concentrations of 0.005, 0.01, 0.05, 0.1, and 1 μg/mL. The effect of the CNPs on the proliferation of hepatoma cells were detected by an electrochemical method. The expressions of the Bcl-2 and Bax mRNAs were evaluated by qRT-PCR. Additionally, the effect of CNPs on the cell cycle was investigated by flow cytometry. Low concentrations of CNPs have a proliferative effect on hepatoma cells. qRT-PCR showed that CNPs could inhibit the apoptosis of hepatoma cells. Flow cytometry showed that CNPs had no effect on the hepatocellular carcinoma cell cycle. Low concentrations of CNPs have a proliferative effect on hepatoma cells.A stable monodisperse hydroxyapatite (HAP) nanoparticle suspension was prepared by chemical method-assisted ultrasound irradiation. HAP nanoparticles were characterized by atomic force microscopy (AFM) and particle size potentiometry. The effects of HAP nanoparticles on BEL-7402 human hepatocarcinoma cells were studied by MTT colorimetric assay and morphological observation. The mechanism of HAP nanoparticles was studied by analyzing single cell fluorescence element microregion, the change of ultrastructure and cell cycle. The experimental results show that HAP nanoparticles have an obvious inhibitory effect on BEL-7402 human hepatocarcinoma cells in vitro. By entering the cancer cells and blocking the progress of cell cycle, HAP nanoparticles induce the accumulation of cells in G1 phase, which leads to cancer cell swelling and apoptosis.Unstable atherosclerotic (AS) plaques contain numerous macrophages that can phagocytose a specific contrast agent, namely ultrafine superparamagnetic iron oxide (USPIO). This study prepared USPIO nanoparticles, defined their physical and magnetic properties and transmission characteristics, explored the feasibility of their use as a magnetic resonance negative contrast agent, and used them to detect unstable AS plaque as a specific marker of macrophages. We randomly divided 20 healthy male New Zealand white rabbits into two groups, experimental and control (n = 10 each). The experimental group was fed pure high-fat feed. The magnetic resonance imaging (MRI) performance of arterial plaque before and after USPIO enhancement compare with pathological results. The experimental group successfully established a rabbit AS plaque model, and 8 of 10 rabbits developed AS plaque. USPIO-enhanced T2W1 sequence showed that the central signal of the plaque was reduced, and the signal-to-noise ratio of the vascular wall was the lowest at 96 h. The control group showed no change in the wall signal before and after enhancement. The USPIO-enhanced PJN2D-TOF sequence showed dotted filling defects on the tube wall. Pathological examination showed that USPIO nanoparticles were mainly deposited under the arterial intima. A simple high-fat diet can establish a rabbit AS plaque model, and USPIO-enhanced MRI reflects the condition of rabbit AS plaque, which is helpful in evaluating AS lesion diagnosis.This study aims to compare the efficacy and side effects of albumin-binding paclitaxel plus carboplatin (NAB PC) and paclitaxel plus carboplatin (PC) in the first-line treatment of advanced non-small cell lung cancer (NSCLC). A total of 60 patients with advanced NSCLC diagnosed by histopathology or cytology were randomly divided into nab PC group (albumin-binding paclitaxel 130 mg/mL, D1, D; carboplatin AUC = 6, D1) and PC group (paclitaxel 175 mg/mL, D1; carboplatin AUC = 6, D1), one cycle every three weeks. RECIST 1.1 standard was used to evaluate the short-term objective efficacy, and who acute and subacute toxicity classification standard was used to evaluate the toxicity. The total effective rate (RR) and disease control rate (DCR) of NAB PC group were 40.0% and 80.0%, respectively, which were higher than 23.3% and 60.0% of the PC group, respectively. This difference was statistically significant (p 0.05). The incidence of neutropenia in the NAB PC group was higher than that in the PC group (p less then 0.05). The therapeutic effect of paclitaxel combined with carboplatin in the treatment of advanced NSCLC is better, the effect of paclitaxel combined with carboplatin is better, and the side effects can be tolerated, which is worthy of clinical application. Patients are more satisfied with their care.To systematically evaluate the efficacy and safety of oxetam in the treatment of vascular cognitive dysfunction and the feasibility of an Au/polypropionic acid Nanometer drug delivery system to provide evidence for clinical application. PubMed, Shanghai embase, Cochrane Library, CNKI, VIP information, and Wanfang database were searched from the establishment of the database to April 2018. mTOR inhibitor Patients were divided into two groups according to whether they received olacetam the experimental group and the control group. In addition, the control group was divided into the placebo control group and the positive control group according to whether the control group received a placebo or other medication treatment controls. In the control group, a meta-analysis, a publication bias assessment, and sensitivity analysis were performed with Revman 5.3 and Stata 14.0. The results of the meta-analysis showed that compared with placebo and other medications, oxiracetam significantly improved the mental status of patients, Concise Mental State Checklist score [mean difference (MD)= 5.29, P 0.05). Based on the current clinical evidence, olacetam is more effective and safer than alternatives in the treatment of vascular cognitive dysfunction.TIMP2 has been previously reported to be associated with acute kidney injury (AKI); however, the underlying mechanism remains unclear. Therefore, the present study investigated the regulation of TIMP2 in human tubular epithelial cells HK-2 cells. Proliferation of HK-2 cells treated by TIMP2 at normal expression level was detected. GST pulldown and mass spectrometry were performed to investigate the interacting protein of TIMP2 and immunofluorescence test was used to determine the location of the protein in HK-2 cells. Cell viability as well as the expression level of CCND1, C-FOS, MAPK1 and P-MAPK1 were detected in the samples treated by overexpressed TIMP2 and the inhibitor of the interacting protein KIT. TIMP2 significantly inhibited cell proliferation compared with the control and BB-94-treated groups (P less then 0.05). KIT was identified as the interacting protein of TIMP2, and was located in both the cytoplasm and membrane of HK-2 cells. Inhibited KIT and the overexpressed of TIMP2 both significantly suppressed cell proliferation and decreased the expression levels of CCND1, MAPK1, and P-MAPK1 compared with the control (P less then 0.05). No significant difference was observed in cell proliferation and the expression level of aforementioned proteins between overexpressed TIMP2 and KIT-inhibited group. The results revealed that TIMP2 regulates cell proliferation by reducing the expression levels of CCND1, MAPK1, and P-MAPK1 via KIT, indicating that TIMP2 directly regulates cell proliferation without inhibiting matrix metalloproteinases in AKI. Furthermore, PLA-PEG nanoparticles successfully transported TIMP2 to the target with no significant effect on cell proliferation.This study investigated the effect of nano-Ag/TiO₂ composite antibacterial agent on bacterial vaginosis and trichomonas vaginitis. Bacterial vaginosis and trichomonas vaginitis were treated with nano-Ag/TiO₂ composite antibacterial agent (composite treatment group) and ornidazole suppository (traditional treatment group). Vaginal secretions from both treatment groups were analyzed to determine the effectiveness of the methods. The effective rate of the nano-Ag/TiO₂ composite antibacterial agent was 97.0% for bacterial vaginosis and 94.4% for trichomonas vaginitis. The traditional treatment method, ornidazole suppository, showed an effective rate of 79.5% for bacterial vaginitis and 88.9% for trichomonas vaginitis. Therefore, the nano-Ag/TiO₂ composite antibacterial agent was determined to be an effective treatment method for bacterial vaginosis and trichomonas vaginitis.To study the effects of drug delivery using solid lipid nanoparticles in the treatment of acute noise exposure-induced cochlea damage. The solid lipid nanoparticles (SLNs) were used as carriers to effectively encapsulate the drug clozapine, improve drug stability in the carrier system, and increase drug bioavailability in vivo. Solid lipid nanoparticles carrying clozapine were produced by ultrasonic technology. The clozapine solution or sulphate SLN was administered though intratympanic or intravenous injection on the first day of noise exposure Guinea pigs were exposed to 110 dB sound pressure level (SPL) noise (2 h per day with center frequencies of 0.25-4.0 kHz for 4 days). After noise exposure, the guinea pigs were subjected to auditory brainstem response (ABR) threshold measurements. Reactive oxygen species (ROS) levels were detected in the cochlea by electron spin resonance (ESR), and outer hair cell counts (OHCs) were obtained using silver nitrate (AgNO₃). link2 SLN particles carrying clozapine exhibited protective effects on the cochlea. The threshold shift and ROS production in treated animals, especially in animals treated with clozapine SLN through intraperitoneal injection, were significantly lower than those in untreated animals.In this study, we investigated the hyperthermia efficiency of magnetic hyperthermia therapy (MHT), photo-thermal therapy (PTT), and the combination of both techniques by employing SPIO-based magneto-nanomicelles as the heating agents. Magneto-nanomicelles in aqueous suspension were exposed to 808-nm laser irradiation (PTT mode), alternating magnetic field (MHT mode), and both modalities (DUAL mode). All the three methods can offer effective temperature increases (above 20 °C). DUAL-mode resulted in an approximately 2-fold increase in heating efficiency (36 °C) compared with PTT or MHT alone. For in vivo experiments, a total of 24 Lewis carcinoma-bearing mice were randomly divided into four groups the control group (no therapy), PTT, MHT, and DUAL group. In the three therapy groups, magneto-nanomicelles were injected into the tumor and the corresponding treatment measures were performed every other day for a total of three times each. MRI scans were used to calculate tumor volume after each treatment. One-way analysis of variance (ANOVA) was employed to compare the curative effect of different treatment groups. Compared with the control group, PTT, MHT, and DUAL groups all showed a significant inhibitory effect on tumor volume (P less then 0.05). In the DUAL group, the mean tumor volume was smaller than that of the PTT or the MHT group. Our work demonstrated that hyperthermia using SPIO-based magnetonanomicelles has a remarkable suppressive effect in anticancer therapy. link3 Moreover, the combined model of hyperthermia in vivo can achieve synthetic effects with shorter healing time by using the same magneto-nanomicelles.